SBRA’s Stock Market Puzzle: Piecing Together 2025’s Performance

ZM Stock

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 11.55%. However, over the last six months, the performance has been weaker by 14.10%. The price of SBRA increased 0.65% over the last 30 days. And in the last five days, it has surged by 0.65%.

Sabra Healthcare REIT Inc (SBRA) stock is currently valued at $18.53. During the last session, the stock experienced a remarkable rise, reaching $22.0 after opening at $18.53. The stock briefly dropped to $18.0 before ultimately closing at $18.63.

The market performance of Sabra Healthcare REIT Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $19.99 on 11/12/24, while the lowest value for the same duration was $15.60 on 02/21/25.

52-week price history of SBRA Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Sabra Healthcare REIT Inc’s current trading price is -7.31% away from its 52-week high, while its distance from the 52-week low is 18.82%. The stock’s price range during this time has been between $15.60 and $19.99. The trading volume for the Real Estate sector company’s shares reached about 4.54 million for the day, which was higher than the average daily volume of 2.55 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Sabra Healthcare REIT Inc (SBRA) has experienced a quarterly rise of 4.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.44B and boasts a workforce of 50 employees.

Sabra Healthcare REIT Inc: Analysts’ Ratings Unveiled

As of right now, 5 analysts are rating Sabra Healthcare REIT Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 17.91, with a change in price of +1.20. Similarly, Sabra Healthcare REIT Inc recorded 2,569,198 in trading volume during the last 100 days, posting a change of +6.92%.

SBRA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SBRA stands at 0.93. Similarly, the long-term debt-to-equity ratio is also 0.92.

SBRA Stock Stochastic Average

Today, Sabra Healthcare REIT Inc’s raw stochastic average for the past 50 days stands at 75.41%, indicating a rise from the raw stochastic average of the last 20 days, which was 66.36%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 72.73% and 75.07% respectively.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.